MX9205367A - RECOMBINANT PIV3 PROTEINS AND VACCINE THAT INCLUDES THEM. - Google Patents

RECOMBINANT PIV3 PROTEINS AND VACCINE THAT INCLUDES THEM.

Info

Publication number
MX9205367A
MX9205367A MX9205367A MX9205367A MX9205367A MX 9205367 A MX9205367 A MX 9205367A MX 9205367 A MX9205367 A MX 9205367A MX 9205367 A MX9205367 A MX 9205367A MX 9205367 A MX9205367 A MX 9205367A
Authority
MX
Mexico
Prior art keywords
vaccine
recombinant piv3
proteins
piv3 proteins
recombinant
Prior art date
Application number
MX9205367A
Other languages
Spanish (es)
Inventor
Dirk Gheysen
Alex Bollen
Lydia Blaise
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of MX9205367A publication Critical patent/MX9205367A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX9205367A 1991-09-23 1992-09-22 RECOMBINANT PIV3 PROTEINS AND VACCINE THAT INCLUDES THEM. MX9205367A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919120221A GB9120221D0 (en) 1991-09-23 1991-09-23 Novel compounds

Publications (1)

Publication Number Publication Date
MX9205367A true MX9205367A (en) 1993-03-01

Family

ID=10701826

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205367A MX9205367A (en) 1991-09-23 1992-09-22 RECOMBINANT PIV3 PROTEINS AND VACCINE THAT INCLUDES THEM.

Country Status (6)

Country Link
AU (1) AU2566092A (en)
GB (1) GB9120221D0 (en)
MX (1) MX9205367A (en)
PT (1) PT100885A (en)
WO (1) WO1993006218A2 (en)
ZA (1) ZA927199B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270181A (en) * 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5723130A (en) † 1993-05-25 1998-03-03 Hancock; Gerald E. Adjuvants for vaccines against respiratory syncytial virus
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US7465574B2 (en) 1994-09-30 2008-12-16 Medimmune, Llc Recombinant RSV virus expression systems and vaccines
FR2726471B1 (en) 1994-11-07 1997-01-31 Pf Medicament PROCESS FOR IMPROVING THE IMMUNOGENICITY OF AN IMMUNOGENIC COMPOUND OR A HAPTENA AND APPLICATION TO THE PREPARATION OF VACCINES
GB9513683D0 (en) * 1995-07-05 1995-09-06 Ciba Geigy Ag Products
JPH11513372A (en) * 1995-09-22 1999-11-16 コノート ラボラトリーズ リミテッド Parainfluenza virus glycoproteins and vaccines
US6830748B1 (en) 1997-09-26 2004-12-14 Medimmune Vaccines, Inc. Recombinant RSV virus expression systems and vaccines
KR20120093811A (en) 2009-06-24 2012-08-23 아이디 바이오메디컬 코포레이션 오브 퀘벡 Vaccine
CN104513317B (en) * 2013-09-30 2018-12-14 普莱柯生物工程股份有限公司 A kind of vaccine composition and its preparation method and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU611784B2 (en) * 1988-04-22 1991-06-20 Pharmacia & Upjohn Company Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3

Also Published As

Publication number Publication date
AU2566092A (en) 1993-04-27
PT100885A (en) 1993-11-30
WO1993006218A3 (en) 1993-05-27
GB9120221D0 (en) 1991-11-06
WO1993006218A2 (en) 1993-04-01
ZA927199B (en) 1993-06-14

Similar Documents

Publication Publication Date Title
DK19991D0 (en) PROTEIN PREPARATIONS
DK91192D0 (en) PROTEIN
ATA902590A (en) RECOMBINANT SMALL VIRUS
NO921012D0 (en) PHARMACEUTICAL PREPARATIONS AND THEIR USE
NO924060D0 (en) PEG IMIDATES AND PROTEIN DERIVATIVES THEREOF
BR9206131A (en) Hepatitis C: diagnosis and vaccines
DE69230637D1 (en) Ventilator
ATE120489T1 (en) RECOMBINANT COCCIDIOSIS VACCINE.
DE69230127D1 (en) Diagram recognition system
ATE189480T1 (en) RECOMBINANT AVIPOXVIRUS
DE59206911D1 (en) AIR HEATER
FI952069A (en) Low allergenic proteins
ITMI921007A1 (en) SHOOTING-CLAMPING CIRCUIT AND OUTPUT BUFFER CIRCUIT USING THE SAME.
DE4192786T1 (en) Measles Virus Recombinant Smallpox Virus Vaccine
MX9205367A (en) RECOMBINANT PIV3 PROTEINS AND VACCINE THAT INCLUDES THEM.
FI934588A (en) INSULINLINE VAEXTFAKTOR BINDANDE PROTEIN HAERSTAMMANDE FRAON MAENNISKOBEN
FI955605A (en) Arylating drugs
DE69230320D1 (en) Amplifier with several switched stages
FI961869A (en) Vaccine design and manufacture
NO892948L (en) MODIFIED PROTEINS.
FI942467A (en) Protease stable proteins
ATE165620T1 (en) VACCINES BASED ON MODIFIED BOVINE HERPES VIRUSES TYPE 1
DE69123089D1 (en) Amine-enriched proteins
NO933600D0 (en) TERMOSTABILE VIRUS
DK149591A (en) protein preparation